4.7 Article Proceedings Paper

An enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data

期刊

BIOINFORMATICS
卷 27, 期 13, 页码 I310-I316

出版社

OXFORD UNIV PRESS
DOI: 10.1093/bioinformatics/btr202

关键词

-

资金

  1. NCI NIH HHS [U54CA149196, U54 CA149196] Funding Source: Medline

向作者/读者索取更多资源

Motivation: Prediction of synergistic effects of drug combinations has traditionally been relied on phenotypic response data. However, such methods cannot be used to identify molecular signaling mechanisms of synergistic drug combinations. In this article, we propose an enhanced Petri-Net (EPN) model to recognize the synergistic effects of drug combinations from the molecular response profiles, i.e. drug-treated microarray data. Methods: We addressed the downstream signaling network of the targets for the two individual drugs used in the pairwise combinations and applied EPN to the identified targeted signaling network. In EPN, drugs and signaling molecules are assigned to different types of places, while drug doses and molecular expressions are denoted by color tokens. The changes of molecular expressions caused by treatments of drugs are simulated by two actions of EPN: firing and blasting. Firing is to transit the drug and molecule tokens from one node or place to another, and blasting is to reduce the number of molecule tokens by drug tokens in a molecule node. The goal of EPN is to mediate the state characterized by control condition without any treatment to that of treatment and to depict the drug effects on molecules by the drug tokens. Results: We applied EPN to our generated pairwise drug combination microarray data. The synergistic predictions using EPN are consistent with those predicted using phenotypic response data. The molecules responsible for the synergistic effects with their associated feedback loops display the mechanisms of synergism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Clinical Implications of Genetic Signatures in Appendiceal Cancer Patients with Incomplete Cytoreduction/HIPEC

Omeed Moaven, Jing Su, Guangxu Jin, Konstantinos Votanopoulos, Perry Shen, Christopher Mangieri, Stacey S. O'Neill, Kathleen C. Perry, Edward A. Levine, Lance D. Miller

ANNALS OF SURGICAL ONCOLOGY (2020)

Article Biochemical Research Methods

Origin-independent analysis links SARS-CoV-2 local genomes with COVID-19 incidence and mortality

Wenzhong Yang, Guangxu Jin

Summary: The study reveals that the uneven distribution of genetic variations of the novel coronavirus SARS-CoV-2 among geographic regions is strongly correlated with the incidence and mortality of COVID-19.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Oncology

TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers

Angelina T. Regua, Noah R. Aguayo, Sara Abu Jalboush, Daniel L. Doheny, Sara G. Manore, Dongqin Zhu, Grace L. Wong, Austin Arrigo, Calvin J. Wagner, Yang Yu, Alexandra Thomas, Michael D. Chan, Jimmy Ruiz, Guangxu Jin, Roy Strowd, Peiqing Sun, Jiayuh Lin, Hui-Wen Lo

Summary: The study identified a novel co-activation of TrkA and STAT3 in triple-negative and HER2-enriched breast cancers, enhancing gene transcription and promoting breast cancer stem cells. The findings revealed that TrkA is a new activating kinase of STAT3, leading to increased aggressiveness of breast cancer through enhanced stem cell renewal and gene expression.

CANCERS (2021)

Article Oncology

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy

Chao Gao, Guangxu Jin, Elizabeth Forbes, Lingegowda S. Mangala, Yingmei Wang, Cristian Rodriguez-Aguayo, Paola Amero, Emine Bayraktar, Ye Yan, Gabriel Lopez-Berestein, Russell R. Broaddus, Anil K. Sood, Fengxia Xue, Wei Zhang

Summary: Research found that IK somatic mutations are more common in high-grade and high-stage endometrial cancer patients, who have longer survival periods. These mutations are related to the pathophysiology of EC and have a role in promoting cell cycle progression.

CANCERS (2021)

Article Biochemical Research Methods

hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy

Yong Lu, Gang Xue, Ningbo Zheng, Kun Han, Wenzhong Yang, Rui-Sheng Wang, Lingyun Wu, Lance D. Miller, Timothy Pardee, Pierre L. Triozzi, Hui-Wen Lo, Kounosuke Watabe, Stephen T. C. Wong, Boris C. Pasche, Wei Zhang, Guangxu Jin

Summary: A new algorithm called hDirect-MAP has been developed to map T cells into a shared high-dimensional expression space in order to identify T cell phenotypes that respond to immune checkpoint blockade in specific types of cancer. By removing non-contributing cells and grouping T cells based on functional markers, hDirect-MAP can provide a generalizable and accurate predictive biomarker.

BRIEFINGS IN BIOINFORMATICS (2022)

Article Oncology

Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells

Gang Xue, Ningbo Zheng, Jing Fang, Guangxu Jin, Xiaoyin Li, Gianpietro Dotti, Qing Yi, Yong Lu

Summary: This research demonstrates that tumor-specific Th9 cells have a unique capacity to eliminate advanced tumors containing ALVs, attributed to their enhanced direct tumor cell killing and interferon alpha/beta-induced bystander antitumor effects. This is due to the accumulation of extracellular ATP within the tumor microenvironment, promoting immune cell infiltration and antitumor cytokine production.

CANCER CELL (2021)

Article Oncology

NEDD4 degrades TUSC2 to promote glioblastoma progression

Tadas K. Rimkus, Austin B. Arrigo, Dongqin Zhu, Richard L. Carpenter, Sherona Sirkisoon, Daniel Doheny, Angelina T. Regua, Grace L. Wong, Sara Manore, Calvin Wagner, Hui-Kuan Lin, Guangxu Jin, Jimmy Ruiz, Michael Chan, Waldemar Debinski, Hui-Wen Lo

Summary: The study found that TUSC2 protein expression is reduced in glioblastoma compared to normal brain due to protein destabilization. NEDD4-mediated polyubiquitination is a novel mechanism for TUSC2 degradation in glioblastoma. TUSC2 loss promotes glioblastoma progression through upregulation of Bcl-xL and its knockout gene signature predicts poor patient survival.

CANCER LETTERS (2022)

Correction Oncology

Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis (vol 78, pg 4316, 2018)

Fei Xing, Yin Liu, Shih-Ying Wu, Kerui Wu, Sambad Sharma, Yin-Yuan Mo, Jiamei Feng, Stephanie Sanders, Guangxu Jin, Ravi Singh, Pierre-Alexandre Vidi, Abhishek Tyagi, Michael D. Chan, Jimmy Ruiz, Waldemar Debinski, Boris C. Pasche, Hui-Wen Lo, Linda J. Metheny-Barlow, Ralph B. D'Agostino, Kounosuke Watabe

CANCER RESEARCH (2021)

Article Oncology

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes

Ashok K. Pullikuth, Eric D. Routh, Kip D. Zimmerman, Julia Chifman, Jeff W. Chou, Michael H. Soike, Guangxu Jin, Jing Su, Qianqian Song, Michael A. Black, Cristin Print, Davide Bedognetti, Marissa Howard-McNatt, Stacey S. O'Neill, Alexandra Thomas, Carl D. Langefeld, Alexander B. Sigalov, Yong Lu, Lance D. Miller

Summary: High TREM-1 expression is associated with poor prognosis in breast cancer, potentially contributing to tumor progression and immune suppression through myeloid cells.

FRONTIERS IN ONCOLOGY (2021)

Article Engineering, Biomedical

Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells

Gang Xue, Ziyu Wang, Ningbo Zheng, Jing Fang, Chengqiong Mao, Xiaoyin Li, Guangxu Jin, Xin Ming, Yong Lu

Summary: Targeting tumor cells can promote resistance to immune checkpoint blockade therapy, but this resistance can be overcome by depleting tumor cells and immunosuppressive cells simultaneously using a monoclonal antibody binding CD73 enzyme. This approach prevents tumors from acquiring resistance to immune checkpoint blockade and leads to the eradication of advanced tumors.

NATURE BIOMEDICAL ENGINEERING (2021)

Article Biochemical Research Methods

VOC-alarm: mutation-based prediction of SARS-CoV-2 variants of concern

Hongyu Zhao, Kun Han, Chao Gao, Vithal Madhira, Umit Topaloglu, Yong Lu, Guangxu Jin

Summary: This article introduces a method called VOC-alarm to predict variant of concern (VOCs) and their impact on COVID surges by analyzing mutations in SARS-CoV-2 sequences. The study found that VOCs rely on lineage-level entropy of mutation numbers to compete with other variants, highlighting the importance of population-level mutations in virus evolution. By simulating the mutational process, the authors predicted the mutation patterns of Alpha, Delta, Delta Plus, and Omicron in different stages, and also predicted that Omicron could lead to another COVID surge from January 2022 to March 2022.

BIOINFORMATICS (2022)

Article Oncology

Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases

Sherona R. Sirkisoon, Grace L. Wong, Noah R. Aguayo, Daniel L. Doheny, Dongqin Zhu, Angelina T. Regua, Austin Arrigo, Sara G. Manore, Calvin Wagner, Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui-Wen Lo

Summary: This study demonstrates that miR-1290 and miR-1246 derived from extracellular vesicles (EVs) secreted by breast cancer cells activate astrocytes, promoting brain metastasis. The activation of astrocytes is mediated by the suppression of FOXA2 and subsequent secretion of CNTF cytokine through the EV-miR-1290 -> FOXA2 -> CNTF signaling axis.

CANCER LETTERS (2022)

Article Oncology

Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance

Ningbo Zheng, Jing Fang, Gang Xue, Ziyu Wang, Xiaoyin Li, Mengshi Zhou, Guangxu Jin, Masmudur M. Rahman, Grant McFadden, Yong Lu

Summary: In this study, tumor-specific T cells infected with myxoma virus were used to deliver the virus into solid tumors, overcoming primary resistance. In addition to inducing classic tumor cell apoptosis and pyroptosis, these infected T cells were found to induce a special type of cell death called tumor cell autosis, which helps to restrain tumor antigen escape.

CANCER CELL (2022)

Meeting Abstract Oncology

Astrocytes activated by tGLI1-expressing breast cancer brain metastases upregulate CNTF to activate astrocytes and promote breast cancer stem cells

Grace L. Wong, Sherona R. Sirkisoon, Noah R. Aguayo, Daniel L. Doheny, Dongqin Zhu, Angelina T. Regua, Austin Arrigo, Sara G. Manore, Calvin J. Wagner, Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui-Wen Lo

CANCER RESEARCH (2022)

Meeting Abstract Oncology

JAK2/STAT3 and TrkA pathways are frequently co-activated in triple-negative and HER2-enriched breast cancers and the co-activation correlates with an increased potential of metastasis.

Angelina T. Regua, Noah R. Aguayo, Sara Abu Jalboush, Daniel L. Doheny, Sara G. Manore, Dongqin Zhu, Grace L. Wong, Austin Arrigo, Calvin J. Wagner, Yang Yu, Karen Baylon, Alexandra Thomas, Michael D. Chan, Jimmy Ruiz, Guangxu Jin, Roy E. Strowd, Peiqing Sun, Linda J. Metheny-Barlow, Jiayuh Lin, Hui-Wen Lo

CANCER RESEARCH (2021)

暂无数据